AFT Pharmaceuticals
AFT.NZ
#8581
Rank
โ‚น20.32 B
Marketcap
โ‚น193.83
Share price
-0.29%
Change (1 day)
49.45%
Change (1 year)

Revenue for AFT Pharmaceuticals (AFT.NZ)

Revenue in 2025: โ‚น11.07 Billion

According to AFT Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น11.07 Billion. In 2025 the company made a revenue of โ‚น11.07 Billion an increase over the revenue in the year 2024 that were of โ‚น11.04 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AFT Pharmaceuticals from 2016 to 2025

Annual revenue

Year Revenue Change
2025โ‚น11.07 B0.31%
2024โ‚น11.04 B19.03%
2023โ‚น9.27 B8.4%
2022โ‚น8.55 B13.98%
2021โ‚น7.50 B25.69%
2020โ‚น5.97 B8.18%
2019โ‚น5.52 B0.5%
2018โ‚น5.49 B19.09%
2017โ‚น4.61 B9.56%
2016โ‚น4.21 B